Northwestern University- Lake Forest Hospital

Lake Forest, Illinois 60045

0 studies enrolling now · 7 studies all time

What they study most

Adult Liposarcoma, Aggressive Non-Hodgkin Lymphoma, Anaplastic (Malignant) Meningioma, Atypical Meningioma, B-Cell Non-Hodgkin Lymphoma, Breast Carcinoma Metastatic in the Bone, CD20 Positive, Circulating Tumor Cell Count, Contiguous Stage II Mantle Cell Lymphoma, Diffuse Large B-Cell Lymphoma Unclassifiable, Estrogen Receptor Negative, Estrogen Receptor Positive

Studies at this site

• Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma — Recruiting now
• Ibrutinib After Intensive Induction in Treating Patients With Previously Untreated Mantle Cell Lymphoma — Completed
• Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma — Paused
• Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas — Completed
• MEDI4736 and Tremelimumab in Treating Patients With Metastatic HER2 Negative Breast Cancer — Completed
• Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery — Status unconfirmed
• Denosumab in Treating Patients With ER and/or PR Positive, HER2 Negative Metastatic Breast Cancer With Bone Metastases and Detectable Circulating Tumor Cells — Stopped early